What they were paid
Deciphera Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2023 | $57,460 | $0 | $328,593 | $0 | $386,053 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Deciphera Pharmaceuticals, Inc. DEF 14A filed April 25, 2024, accession 0001654151-24-000012, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2023Deciphera Pharmaceuticals pays directors a $50,000 cash retainer.
Committees
FY2023 · as the proxy prints themCompensation
The rest of the Deciphera Pharmaceuticals board
FY2023 · as the company reported each| Director | Role | FY2023 total |
|---|---|---|
| Edward J. Benz Jr., M.D | Independent Director | $396,093 |
| Frank S. Friedman | Independent Director | $382,303 |
| James A. Bristol, Ph.D | Independent Director | $414,767 |
| John R. Martin | Independent Director | $388,593 |
| Patricia L. Allen | Independent Director | $398,553 |
| Ron Squarer | Chair of the Board | $403,295 |
| Steven L. Hoerter | Director | $0 |
| Susan L. Kelley, M.D | Independent Director | $396,053 |
The full Deciphera Pharmaceuticals compensation record
free company briefThis page is one director within Deciphera Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat